Works matching AU Delmar, Paul


Results: 47
    1
    2

    Japanese participant data from three gantenerumab trials in early Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 4, p. 1, doi. 10.1002/alz.70192
    By:
    • Asada, Takashi;
    • Thanasopoulou, Angeliki;
    • Delmar, Paul;
    • Wojtowicz, Jakub;
    • Smith, Janice;
    • Yoshiyama, Yasumasa;
    • Yokoi, Katsunori;
    • Watanabe, Chigusa;
    • Isozaki, Mitsuhiro;
    • Ozaki, Ryoto;
    • Ishida, Takaaki;
    • Tatsuda, Hironori;
    • Tamaoka, Akira
    Publication type:
    Article
    3

    Biomarker treatment effects in two phase 3 trials of gantenerumab.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14414
    By:
    • Bittner, Tobias;
    • Tonietto, Matteo;
    • Klein, Gregory;
    • Belusov, Anton;
    • Illiano, Vittorio;
    • Voyle, Nicola;
    • Delmar, Paul;
    • Scelsi, Marzia A.;
    • Gobbi, Susanna;
    • Silvestri, Erica;
    • Barakovic, Muhamed;
    • Napolitano, Antonio;
    • Galli, Christopher;
    • Abaei, Maryam;
    • Blennow, Kaj;
    • Barkhof, Frederik
    Publication type:
    Article
    4
    5
    6
    7

    GRADUATE I AND II: Revisiting the key findings from two Phase III studies evaluating the efficacy and safety of subcutaneous gantenerumab in early Alzheimer's disease (AD).

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082977
    By:
    • Lane, Christopher;
    • Smith, Janice;
    • Perry, Richard J;
    • Grimmer, Timo;
    • Lansdall, Claire J;
    • Voyle, Nicola;
    • Delmar, Paul;
    • Bittner, Tobias;
    • Klein, Gregory;
    • Schwab, Dietmar;
    • Schneider, Andres;
    • Salloway, Stephen;
    • Cummings, Jeffrey L.;
    • Baudler, Monika;
    • Fontoura, Paulo;
    • Doody, Rachelle S.
    Publication type:
    Article
    8

    Open RoAD: Design and baseline characteristics of an open‐label rollover study evaluating long‐term safety and tolerability of subcutaneous gantenerumab in participants with early Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.063261
    By:
    • Neve, Anuja;
    • Bullain, Szofia;
    • Das, Bibha;
    • Huang, Zhiyue;
    • Watkin, Michelle;
    • Delmar, Paul;
    • Klein, Gregory;
    • Bittner, Tobias;
    • Lott, Dominik;
    • Smith, Janice;
    • Kerchner, Geoffrey A.;
    • Fontoura, Paulo;
    • Baudler, Monika;
    • Doody, Rachelle S.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Allowing "rescue therapy" in preclinical Alzheimer's trials.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.061805
    By:
    • Donohue, Michael C.;
    • Insel, Philip S.;
    • Aisen, Paul;
    • Delmar, Paul;
    • Giacobino, Caroline;
    • Ostrowitzki, Susanne;
    • Fontoura, Paulo;
    • Doody, Rachelle S.
    Publication type:
    Article
    14
    15
    16

    Comparing ARIA‐E severity scales and effects of treatment management thresholds.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.063848
    By:
    • Klein, Gregory;
    • Bracoud, Luc;
    • Purcell, Derk;
    • Barakos, Jerome;
    • Fiebach, Jochen B.;
    • Scelsi, Marzia A.;
    • Delmar, Paul;
    • Lyons, Marco;
    • Wojtowicz, Jakub;
    • Bullain, Szofia;
    • Barkhof, Frederik;
    • Fontoura, Paulo;
    • Baudler, Monika;
    • Doody, Rachelle S.
    Publication type:
    Article
    17
    18
    19

    Cognitive and functional progression along the continuum from mild cognitive impairment (MCI) to Alzheimer's disease (AD): A latent class analysis using the U.S. National Alzheimer's Coordinating Center (NACC) data set: Epidemiology / Risk and protective factors in MCI and dementia

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040906
    By:
    • Mouchet, Julie;
    • Betts, Keith A.;
    • Ionescu‐Ittu, Raluca;
    • Butler, Lesley M.;
    • Delmar, Paul;
    • Georgieva, Mihaela V.;
    • Kulalert, Thomas;
    • Desai, Urvi
    Publication type:
    Article
    20
    21
    22

    O3‐10‐01: CORRELATION BETWEEN AMYLOID REDUCTION AND CLINICAL OUTCOMES: EXPLORATORY ANALYSES FROM THE GANTENERUMAB SCARLET ROAD AND MARGUERITE ROAD OPEN‐LABEL EXTENSION STUDIES.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P908, doi. 10.1016/j.jalz.2019.06.4678
    By:
    • Delmar, Paul;
    • Kerchner, Geoffrey A.;
    • Wang, Guoqiao;
    • Bateman, Randall;
    • Klein, Gregory;
    • Rehal, Sunita;
    • Voyle, Nicola;
    • Andjelkovic, Mirjana;
    • Abi-Saab, Danielle;
    • Bullain, Szofia S.;
    • Ristic, Smiljana;
    • Baudler, Monika;
    • Fontoura, Paulo;
    • Doody, Rachelle
    Publication type:
    Article
    23
    24

    O1‐09‐05: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION OF THE SCARLET ROAD STUDY IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE AFTER APPROXIMATELY 2 YEARS OF STUDY DURATION.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P241, doi. 10.1016/j.jalz.2018.06.2382
    By:
    • Andjelkovic, Mirjana;
    • Abi-Saab, Danielle;
    • Delmar, Paul;
    • Pross, Nathalie;
    • Voyle, Nicola;
    • Klein, Gregory;
    • Mertes, Michaela;
    • Ristic, Smiljana;
    • Martenyi, Ferenc;
    • Fontoura, Paulo;
    • Doody, Rachelle
    Publication type:
    Article
    25

    O1‐09‐04: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION (OLE) OF THE MARGUERITE ROAD STUDY IN PATIENTS WITH MILD ALZHEIMER'S DISEASE (AD) AFTER APPROXIMATELY TWO YEARS OF STUDY DURATION.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P241, doi. 10.1016/j.jalz.2018.06.2381
    By:
    • Abi-Saab, Danielle;
    • Andjelkovic, Mirjana;
    • Pross, Nathalie;
    • Delmar, Paul;
    • Voyle, Nicola;
    • Klein, Gregory;
    • Esau, Nelli;
    • Ristic, Smiljana;
    • Martenyi, Ferenc;
    • Fontoura, Paulo;
    • Doody, Rachelle
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    A statistician's perspective on biomarkers in drug development.

    Published in:
    Pharmaceutical Statistics, 2011, v. 10, n. 6, p. 494, doi. 10.1002/pst.532
    By:
    • Jenkins, Martin;
    • Flynn, Aiden;
    • Smart, Trevor;
    • Harbron, Chris;
    • Sabin, Tony;
    • Ratnayake, Jayantha;
    • Delmar, Paul;
    • Herath, Athula;
    • Jarvis, Philip;
    • Matcham, James
    Publication type:
    Article
    36
    37
    38
    39
    40

    A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

    Published in:
    Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0318-y
    By:
    • Ostrowitzki, Susanne;
    • Lasser, Robert A.;
    • Dorflinger, Ernest;
    • Scheltens, Philip;
    • Barkhof, Frederik;
    • Nikolcheva, Tania;
    • Ashford, Elizabeth;
    • Retout, Sylvie;
    • Hofmann, Carsten;
    • Delmar, Paul;
    • Klein, Gregory;
    • Andjelkovic, Mirjana;
    • Dubois, Bruno;
    • Boada, Mercè;
    • Blennow, Kaj;
    • Santarelli, Luca;
    • Fontoura, Paulo
    Publication type:
    Article
    41

    The Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor (PPAR)γ Coactivator-1α and the Nuclear Receptor PPARα Control the Expression of Glycerol Kinase and Metabolism Genes Independently of PPARγ Activation in Human White Adipocytes

    Published in:
    Diabetes, 2007, v. 56, n. 10, p. 2467, doi. 10.2337/db06-1465
    By:
    • Mazzucotelli, Anne;
    • Viguerie, Nathalie;
    • Tiraby, Claire;
    • Annicotte, Jean-Sébastien;
    • Mairal, Aline;
    • Klimcakova, Eva;
    • Lepin, Emmanuelle;
    • Delmar, Paul;
    • Dejean, Sébastien;
    • Tavernier, Genevieve;
    • Lefort, Corinne;
    • Hidalgo, Juan;
    • Pineau, Thierry;
    • Fajas, Lluis;
    • Clément, Karine;
    • Langin, Dominique
    Publication type:
    Article
    42
    43
    44

    Comparing ARIA‐E severity scales and effects of treatment management thresholds.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12376
    By:
    • Klein, Gregory;
    • Scelsi, Marzia A.;
    • Barakos, Jerome;
    • Fiebach, Jochen B.;
    • Bracoud, Luc;
    • Suhy, Joyce;
    • Delmar, Paul;
    • Lyons, Marco;
    • Wojtowicz, Jakub;
    • Bullain, Szofia;
    • Barkhof, Frederik;
    • Purcell, Derk
    Publication type:
    Article
    45
    46
    47